Brendan Delaney - 01 Mar 2023 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: WHWK
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Mar 2023, 15:05:47 UTC
Prior SEC filing: 04 Jan 2023
Next SEC filing: 31 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Stephen Rodin, as Attorney-in-Fact

Key filing fact

Brendan Delaney filed Form 4 for Aadi Bioscience, Inc. (WHWK) on 02 Mar 2023.

Key facts

This page summarizes Brendan Delaney's Form 4 filing for Aadi Bioscience, Inc. (WHWK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2023, 15:05.

Change

Previous filing in this sequence was filed on 04 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AADI transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +235,000
Change %
Price: $0.000000
Shares after: 235,000
Date: 01 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 235,000
Exercise price: $10.93
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.

SEC remarks

President and Chief Executive Officer